Table 1.

Clinical details of patients^{^a}

Patient no.	Age (yr)	Gender	MRI	Medications	Possible location of epileptogenic zone^{^b}
Adults
1	19	Female	No lesion	Carbamazepine; levetiracetam	R frontoparietal
2	30	Male	No lesion	Lamotrigine; levetiracetam	R frontoparietal
3	19	Male	No lesion	Primidone; sulthiame; valproate; clobazam	L > R frontal
4	29	Male	Suspected FCD: L insular and temporal	Oxcarbazepine; valproate; levetiracetam; clobazam	L frontal
5	31	Male	Suspected FCD: L occipital	Clobazam; gabapentin; carbamazepine; oxcarbazepine	L frontotemporal
6	20	Male	A lesion in the left cingulate	Phenobarbital; levetiracetam; phenytoin	L frontotemporal
7	18	Male	No lesion	Oxcarbazepine	R frontal, temporal, and parietal
8	18	Female	Findings of unknown origins	Valproate; carbamazepine	R < L frontal, temporal and parietal
9	36	Female	No lesion	No information	R parietal
10	27	Female	Bilateral perisylvian polymicrogyria	Clobazam; topiramate; valproate; oxcarbazepine	R frontotemporal > parietal
11	29	Male	No lesion	Lamotrigine; valproate	L frontal
12	23	Female	No lesion	Carbamazepine; clonazepam; levetiracetam	R > L frontotemporal
Children
13	7	Female	No lesion	Diazepam	R frontoparietal
14	9.5	Female	Suspected hydrocephalus	Valproate; clobazam; zonisamide	R temporal, parietal, and insula
15	8.5	Male	FCD: R frontal and bilateral cingulate, preventricular heterotopia of gray matter	Levetiracetam; primidone	R frontal
16	14	Male	No lesion	Levetiracetam; ethosuximide	MEG sources diffuse throughout hemisphere R > L (possibly primary generalized seizures)
17	11	Female	Suspected R MTS	Carbamazepine	L frontal > temporal
18	12.5	Male	Suspected FCD: R frontal	Carbamazepine; levetiracetam	R frontal
19	5	Female	No lesion	Levetiracetam; oxcarbazepine	L frontal
20	5.5	Female	No lesion	No information	R frontoinsular > parietal

↵^a FCD, Focal cortical dysplasia; MTS, mesial temporal sclerosis.
↵^b Location of epileptogenic zone was estimated by a combination of imaging modalities, including video-EEG, MEG, and PET.